Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chaitali Nashikkar
Observed names:
C. Nashikkar,
Nashikkar Chaitali
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
Observed institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
ORCID:
0000-0003-0052-3576
Observed ORCID:
0000-0003-0052-3576
OpenAlex ID:
A5064313647
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)
2023
·
Vikas Ostwal
, Sarika Mandavkar
, et al.
·
Journal of Clinical Oncology
·
44
Gemcitabine-cisplatin versus gemcitabine-oxaliplatin doublet chemotherapy in advanced gallbladder cancers: a match pair analysis
2017
·
Anant Ramaswamy
, Vikas Ostwal
, et al.
·
Journal of Hepato-Biliary-Pancreatic Sciences
·
27
Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH)
2022
·
Vikas Ostwal
, Anant Ramaswamy
, et al.
·
The Oncologist
·
18
PDF
Treatment of advanced Gall bladder cancer in the real world—can continuation chemotherapy improve outcomes?
2017
·
Vikas Ostwal
, Rakesh Pinninti
, et al.
·
Journal of Gastrointestinal Oncology
·
16
PDF
Minimally invasive surgery for maximally invasive tumors: pelvic exenterations for rectal cancers
2022
·
Mufaddal Kazi
, Ashwin Desouza
, et al.
·
Daehan nae'si'gyeong bog'gang'gyeong oe'gwa haghoeji/Journal of minimally invasive surgery
·
13
PDF
The use of an obstetric balloon as a pelvic spacer in preventing empty pelvis syndrome after total pelvic exenteration in rectal cancers – A prospective safety and efficacy study for the Bakri balloon
2022
·
Mufaddal Kazi
, Ashwin Desouza
, et al.
·
Colorectal Disease
·
11
Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III Study
2020
·
Vikas Ostwal
, Akhil Kapoor
, et al.
·
The Oncologist
·
11
Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers
2023
·
Sandeep Gedela
, Pritesh Munot
, et al.
·
Journal of Gastrointestinal Cancer
·
10
Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma
2024
·
Manish S. Bhandare
, Vikas Gupta
, et al.
·
HPB
·
8
PDF
Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?
2020
·
Anita D’Souza
, Dipalee Pawar
, et al.
·
South Asian Journal of Cancer
·
8
PDF
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers
2024
·
Anant Ramaswamy
, Prabhat Bhargava
, et al.
·
JNCI Cancer Spectrum
·
7
PDF
Docetaxel/Oxaliplatin/Capecitabine (TEX) triplet followed by continuation monotherapy in advanced gastric cancer
2018
·
Anant Ramaswamy
, Vikas Ostwal
, et al.
·
Indian Journal of Cancer
·
7
Clinical practice and outcomes in advanced gastrointestinal stromal tumor: Experience from an Indian tertiary care center
2017
·
Subhadeep Bose
, Anant Ramaswamy
, et al.
·
South Asian Journal of Cancer
·
7
Is Less “Sufficient” and “Safe” in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma
2026
·
Sumeet Mirgh
, Arti Goel
, et al.
·
Blood Cancer Journal
·
6
PDF
Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial
2024
·
Anant Ramaswamy
, Prabhat Bhargava
, et al.
·
Journal of Clinical Oncology
·
6
A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/5 fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers (DOC-GC study).
2024
·
Anant Ramaswamy
, Prabhat Ghanshyam Bhargava
, et al.
·
Journal of Clinical Oncology
·
4
Use of circular staplers for the creation of abdominal apertures for end colostomies: phase I study
2023
·
Mufaddal Kazi
, Ashwin Desouza
, et al.
·
British journal of surgery
·
4
PDF
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
2018
·
Anant Ramaswamy
, Vikas Ostwal
, et al.
·
South Asian Journal of Cancer
·
3
PDF
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
2016
·
Bhawna Sirohi
, Vikas Ostwal
, et al.
·
Indian Journal of Medical and Paediatric Oncology
·
3
99P Bevacizumab plus erlotinib maintenance versus observation in advanced biliary tract cancers: Results from the phase II component of a prospective integrated phase II-phase III parallel design superiority clinical trial (BEER-BTC study)
2023
·
A. Ramaswamy
, V.S. Ostwal
, et al.
·
Annals of Oncology
·
2
Should anorectal manometry be routine before stoma reversal in patients after an intersphincteric resection?
2023
·
Mufaddal Kazi
, Bhushan Jajoo
, et al.
·
Colorectal Disease
·
2
PDF
Trastuzumab (T) plus gemcitabine-cisplatin (GC) for treatment naïve HER2 positive biliary tract adenocarcinomas (BTC): A multicentre open-label, phase II study (TAB).
2023
·
Vikas S. Ostwal
, Sarika Mandavkar
, et al.
·
Journal of Clinical Oncology
·
2
Carica papaya leaf extract (CPLE) versus placebo to improve chemotherapy induced thrombocytopenia (CIT): Results of a phase III triple blinded, randomized placebo controlled trial (PACT study).
2025
·
Vikas Ostwal
, Manali Parulekar
, et al.
·
Journal of Clinical Oncology
·
1
Real-world effectiveness and safety of adjuvant capecitabine in triple-negative breast cancer (TNBC) patients with residual disease following neoadjuvant chemotherapy.
2026
·
Anbarasan Sekar
, Sanjana Malokar
, et al.
·
Journal of Clinical Oncology
207TiP A two-arm randomized open-label prospective design superiority phase III clinical trial to compare the efficacy of docetaxel-oxaliplatin-capecitabine/ 5 -fluorouracil (DOC/F) followed by docetaxel versus CAPOX/mFOLFOX-7 in advanced gastric cancers
2023
·
P.G. Bhargava
, A. Ramaswamy
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
28
Citation count:
220
H-index:
8
I10-index:
8
Year
Topic
Type